Garware Technical Fibres share news and announcements

NSE: GARFIBRESBSE: 509557Textiles & ApparelsSmall Cap

Formerly Garware Wall Ropes

₹740.30₹9.30 (1.24%)BSE ₹740.75

Share price at the NSE close on 23 Oct 2026. Previous close ₹749.60.

52-week range of traded prices to 23 Oct 2026

₹579.75Low, 30 Mar 2026₹863.40High, 6 Aug 2026

Next results date: the board meets on 29 Oct 2026 to consider: financial results.

Market cap: ₹7,229 Cr702nd largest listed
P/E: 34.4
P/B: 5.3
Dividend yield: 1.22%
ROE: 16.2%
ROCE: 19.3%
Debt to equity: 0.03
Volume, NSE: 39,84746.0% delivered

Garware Technical Fibres board meetings

147 filed, newest first. Page 1 of 3.

Oct 2026
- 22 Oct · Board meeting
  We inform you that a Meeting of the Board of Directors of the Company will be held on Thursday, 29th October, 2026, inter alia, to consider, approve and take on record the Standalone & Consolidated Unaudited Financial Results for the quarter and half year ended 30th September, 2026. (opens in a new tab)
Jul 2026
- 29 Jul · Board meeting
  Intimation of Meeting of the Board of Directors of the Company will be held on Wednesday, 05th August, 2026, inter alia, to consider, approve and take on record the Standalone & Consolidated Unaudited Financial Results for the quarter ended 30th June, 2026. (opens in a new tab)
May 2026
- 13 May · Board meeting
  We inform you that a Meeting of the Board of Directors of the Company will be held on Wednesday, 20th May, 2026, inter alia, to consider, approve and take on record the Standalone & Consolidated Audited Financial Results for the quarter and year ended 31st March, 2026, and to consider and recommend final dividend, if any, for the Financial Year 2025-26. (opens in a new tab)
- 8 May · Board meeting
  Outcome of Board Meeting held on May 08, 2026. (opens in a new tab)
- 5 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 08th May, 2026, inter alia, to consider and approve a proposal for buyback of the equity shares of the Company, having a face value of INR 10/- each, and matters incidental and ancillary thereto. (opens in a new tab)
Feb 2026
- 4 Feb · Board meeting
  We inform you that a Meeting of the Board of Directors of the Company will be held on Wednesday, 11th February, 2026, inter alia, to consider, approve and take on record the Standalone & Consolidated Unaudited Financial Results for the quarter and nine months ended on 31st December, 2025. (opens in a new tab)
Oct 2025
- 31 Oct · Board meeting
  To consider and approve the Standalone & Consolidated Unaudited Financial Results for the quarter and half year ended 30th September, 2025 and to consider declaration of Interim Dividend for the financial year 2025-2026, if any. (opens in a new tab)
Aug 2025
- 8 Aug · Board meeting
  Outcome of Board meeting held on August 08, 2025. (opens in a new tab)
- 1 Aug · Board meeting
  Intimation of Board Meeting to be held on Friday, 8th August, 2025, inter alia, to consider, approve and take on record the Standalone & Consolidated Unaudited Financial Results of the Company for the quarter ended 30th June, 2025. (opens in a new tab)
May 2025
- 8 May · Board meeting
  To consider and approve the Standalone & Consolidated Audited Financial Results for the quarter and year ended 31st March, 2025, and to recommend dividend, if any, for the Financial Year 2024-25. (opens in a new tab)
Feb 2025
- 10 Feb · Board meeting
  Outcome of Board Meeting held on 10th February, 2025 - Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2024 (opens in a new tab)
- 3 Feb · Board meeting
  This is to inform you that a Meeting of the Board of Directors of Garware Technical Fibres Limited ("the Company") will be held on Monday, 10th February, 2025, inter alia, to consider, approve and take on record the Standalone & Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended on 31st December, 2024. (opens in a new tab)
Jan 2025
- 6 Jan · Board meeting
  Board meeting held on January 06, 2025 for allotment of 7,94,12,676 fully paid-up Bonus Equity Shares of Rs. 10/- each in the ratio of 4: 1 i.e., 4 (four) new fully paid-up bonus equity shares of Rs. 10/- each for every 1 (one) existing fully paid-up equity share of Rs. 10/- each, to the eligible members of the Company whose names appeared in the Register of Members / Register of the Beneficial Owners, as on January 03, 2025, the "Record Date" fixed for this purpose.. (opens in a new tab)
Nov 2024
- 14 Nov · Board meeting
  Board meeting held on November 14, 2024 interalia to consider and taken on record Unaudited Standalone and Consolidated Financial Results for the quarter and six months ended on 30th September 2024.. (opens in a new tab)
- 6 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2024 (opens in a new tab)
Aug 2024
- 8 Aug · Board meeting
  Board meeting held on August 08, 2024. (opens in a new tab)
- 1 Aug · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2024 (opens in a new tab)
May 2024
- 27 May · Board meeting
  Outcome of Board Meeting held on 27th May, 2024 including the Audited Standalone and Consolidated Financial Results for the quarter & year ended 31st March, 2024 (opens in a new tab)
- 18 May · Board meeting
  We inform you that a Meeting of the Board of Directors of the Company will be held on Monday, 27th May, 2024, inter alia, to consider, approve and take on record the Standalone & Consolidated Audited Financial Results for the quarter and year ended 31st March, 2024, and to recommend dividend, if any, for the Financial Year 2023-24. (opens in a new tab)
Jan 2024
- 29 Jan · Board meeting
  Outcome of the Board meeting held on January 29, 2024. (opens in a new tab)
- 22 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2023 and buyback for equity shares (opens in a new tab)
Nov 2023
- 6 Nov · Board meeting
  Outcome of the Board Meeting held on 06th November, 2023. (opens in a new tab)
Oct 2023
- 30 Oct · Board meeting
  We inform you that a Meeting of the Board of Directors of the Company will be held on Monday, 06th November, 2023, inter alia, to consider, approve and take on record the Standalone & Consolidated Unaudited Financial Results for the quarter and half year ended 30th September, 2023. (opens in a new tab)
Aug 2023
- 14 Aug · Board meeting
  Outcome of Board Meeting held on 14th August, 2023 including the Unaudited Standalone & Consolidated Financial Results for the quarter ended 30th June, 2023 (opens in a new tab)
- 7 Aug · Board meeting
  We inform you that a Meeting of the Board of Directors of the Company will be held on Monday, 14th August, 2023, inter alia, to consider, approve and take on record the Standalone & Consolidated Unaudited Financial Results for the quarter ended 30th June, 2023. (opens in a new tab)
May 2023
- 22 May · Board meeting
  Board meeting held on May 22, 2023. Outcome of Board Meeting held on 22nd May, 2023 including the Audited Standalone and Consolidated Financial Results for the quarter & year ended 31st March, 2023 (opens in a new tab)
- 15 May · Board meeting
  We inform you that a Meeting of the Board of Directors of the Company will be held on Monday, 22nd May, 2023, inter alia, to consider, approve and take on record the Standalone & Consolidated Audited Financial Results for the quarter and year ended 31st March, 2023, and to recommend dividend, if any, for the Financial Year 2022-23. (opens in a new tab)
Feb 2023
- 2 Feb · Board meeting
  We inform you that a Meeting of the Board of Directors of the Company will be held on Thursday, 09th February, 2023, inter alia, to consider, approve and take on record the Standalone & Consolidated Unaudited Financial Results for the quarter and nine months ended 31st December, 2022. (opens in a new tab)
Oct 2022
- 21 Oct · Board meeting
  Board Meeting held on 21-Oct-2022 to consider financial statements for the period ended September 2022 and Buyback (opens in a new tab)
- 14 Oct · Board meeting
  Board Meeting to be held on 21-Oct-2022 to consider financial statements for the period ended September 2022 and Buyback (opens in a new tab)
Aug 2022
- 5 Aug · Board meeting
  We refer to our letter dated 29th July, 2022 and inform that the Unaudited Standalone & Consolidated Financial Results for the quarter ended 30th June, 2022 were taken on record and approved by the Board of Directors of the Company at its meeting held today i.e. Friday, 05th August, 2022.We refer to the Regulations 30 and 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 and accordingly enclosed herewith:a. The Unaudited Standalone & Consolidated Financial Results for the quarter ended 30th June, 2022.b. Limited Review Report on the Unaudited Standalone & Consolidated Financial Results for the quarter ended 30th June, 2022.The Board Meeting was commenced at 11.00 a.m. and concluded at 2.00 p.m.Trading Window will be re-opened after 48 hours of the conclusion of Board Meeting. (opens in a new tab)
Jul 2022
- 29 Jul · Board meeting
  We inform you that a Meeting of the Board of Directors of the Company will be held on Friday, 05th August, 2022, inter alia, to consider, approve and take on record the Standalone & Consolidated Unaudited Financial Results for the quarter ended 30th June, 2022. (opens in a new tab)
May 2022
- 5 May · Board meeting
  Board Meeting held on 05-May-2022 to consider financial statements for the period ended March 2022, Dividend and Other business matters (opens in a new tab)
Apr 2022
- 29 Apr · Board meeting
  We inform you that a Meeting of the Board of Directors of the Company will be held on Thursday, 05th May, 2022, inter alia, to consider, approve and take on record the Standalone & Consolidated Audited Financial Results for the quarter and year ended 31st March, 2022, and to recommend dividend, if any, for the Financial Year 2021-22. (opens in a new tab)
Feb 2022
- 12 Feb · Board meeting
  Outcome of Board Meeting held on February 12, 2022.Outcome of Board Meeting held on 12th February, 2022 including the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2021We refer to our letter dated 05th February, 2022 and inform that the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2021 were taken on record and approved by the Board of Directors of the Company at its meeting held today i.e. Saturday, 12th February, 2022.We refer to the Regulations 30 and 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 and accordingly enclosed herewith:a. The Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2021.b. Limited Review Report on the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2021.The Board Meeting was commenced at 02.00 p.m. and concluded at 05.00 p.m.Trading Window will be re-opened after 48 hours of the conclusion of Board Meeting. (opens in a new tab)
- 12 Feb · Board meeting
  Board meeting held on February 12, 2022.Outcome of Board Meeting held on 12th February, 2022 including the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2021We refer to our letter dated 05th February, 2022 and inform that the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2021 were taken on record and approved by the Board of Directors of the Company at its meeting held today i.e. Saturday, 12th February, 2022.We refer to the Regulations 30 and 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 and accordingly enclosed herewith:a. The Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2021.b. Limited Review Report on the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2021.The Board Meeting was commenced at 02.00 p.m. and concluded at 05.00 p.m.Trading Window will be re-opened after 48 hours of the conclusion of Board Meeting. (opens in a new tab)
- 5 Feb · Board meeting
  To consider and approve the financial results for the period ended December 31, 2021 (opens in a new tab)
Nov 2021
- 11 Nov · Board meeting
  We refer to our letter dated 03rd November, 2021 and inform that the Unaudited Standalone & Consolidated Financial Results for the quarter and half year ended 30th September, 2021 were taken on record and approved by the Board of Directors of the Company at its meeting held today i.e. Thursday , 11th November, 2021.We refer to the Regulations 30 and 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 and accordingly enclosed herewith:a. The Unaudited Standalone & Consolidated Financial Results for the quarter and half year ended 30th September, 2021.b. Limited Review Report on the Unaudited Standalone & Consolidated Financial Results for the quarter and half year ended 30th September, 2021.Pursuant to Regulation 30 read with Schedule lll of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; we wish to inform that as per the recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company at its meeting held today have resolved,a) To re-designate / appoint Dr. Shridhar Shrikrishna Rajpathak (DIN 00040387) (currently a Non-Executive Non-Independent Director) as a Non-Executive Independent Director of the Company to hold office for a term of five consecutive years with effect from 11th November, 2021 and who shall not be liable to retire by rotation, subject to approval of the Members of the Company.b) To appoint Mr. Sanjay Vasudeo Raut (DIN: 07808549) as an Additional Director (Non-Executive and Non-Independent) of the Company with effect from 11th November, 2021.Dr. Shridhar Shrikrishna Rajpathak and Mr. Sanjay Vasudeo Raut are not debarred from being appointed or to continue as Director of company by virtue of any order of Ministry of Corporate Affairs, (MCA), Securities Exchange Board of India, (SEBI) or any other such statutory authority.The details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular CIR/CFD/CMD/4/2015 dated 9th September, 2015 are enclosed herewith as Annexure A.The Board Meeting was commenced at 03:00 p.m. and concluded at 06.15 p.m.Trading Window will be re-opened after 48 hours of the conclusion of Board Meeting. (opens in a new tab)
- 11 Nov · Board meeting
  Board meeting held on November 11, 2021. (opens in a new tab)
- 3 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2021 (opens in a new tab)
Aug 2021
- 11 Aug · Board meeting
  Outcome of Board Meeting held on August 11, 2021.We refer to our letter dated 04th August, 2021 and inform that the Unaudited Standalone & Consolidated Financial Results for the quarter ended 30th June, 2021 were taken on record and approved by the Board of Directors of the Company at its meeting held today i.e. Wednesday, 11th August, 2021.We refer to the Regulations 30 and 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 and accordingly enclosed herewith:a. The Unaudited Standalone & Consolidated Financial Results for the quarter ended 30th June, 2021.b. Limited Review Report on the Unaudited Standalone & Consolidated Financial Results for the quarter ended 30th June, 2021.The Board Meeting was commenced at 11.00 a.m. and concluded at 01.30 p.m.Trading Window will be re-opened after 48 hours of the conclusion of Board Meeting. (opens in a new tab)
- 11 Aug · Board meeting
  Board meeting held on August 11, 2021.We refer to our letter dated 04th August, 2021 and inform that the Unaudited Standalone & Consolidated Financial Results for the quarter ended 30th June, 2021 were taken on record and approved by the Board of Directors of the Company at its meeting held today i.e. Wednesday, 11th August, 2021.We refer to the Regulations 30 and 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 and accordingly enclosed herewith:a. The Unaudited Standalone & Consolidated Financial Results for the quarter ended 30th June, 2021.b. Limited Review Report on the Unaudited Standalone & Consolidated Financial Results for the quarter ended 30th June, 2021.The Board Meeting was commenced at 11.00 a.m. and concluded at 01.30 p.m.Trading Window will be re-opened after 48 hours of the conclusion of Board Meeting. (opens in a new tab)
- 4 Aug · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2021Pursuant to Regulation 29(1)(a) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, we inform you that a Meeting of the Board of Directors of the Company will be held on Wednesday, 11th August, 2021, inter alia, to consider, approve and take on record the Standalone & Consolidated Unaudited Financial Results for the quarter ended 30th June, 2021. (opens in a new tab)
May 2021
- 27 May · Board meeting
  Outcome of Board Meeting held on 27th May, 2021 including the Audited Standalone & Consolidated Financial Results for the quarter & year ended 31st March, 2021 (opens in a new tab)
- 19 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2021 and dividend (opens in a new tab)
Feb 2021
- 11 Feb · Board meeting
  Outcome of Board Meeting held on February 11, 2021.We refer to our letter dated 04th February, 2021 and inform that the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2020 were taken on record and approved by the Board of Directors of the Company at its meeting held today i.e. Thursday, 11th February, 2021.We refer to the Regulations 30 and 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 and accordingly enclosed herewith:a. The Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2020.b. Limited Review Report on the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2020.The Board Meeting was commenced at 11.00 a.m. and concluded at 02.00 p.m.Trading Window will be re-opened after 48 hours of the conclusion of Board Meeting. (opens in a new tab)
- 11 Feb · Board meeting
  Outcome of Board Meeting held on February 11, 2021.We refer to our letter dated 04th February, 2021 and inform that the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2020 were taken on record and approved by the Board of Directors of the Company at its meeting held today i.e. Thursday, 11th February, 2021.We refer to the Regulations 30 and 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 and accordingly enclosed herewith:a. The Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2020.b. Limited Review Report on the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2020.The Board Meeting was commenced at 11.00 a.m. and concluded at 02.00 p.m.Trading Window will be re-opened after 48 hours of the conclusion of Board Meeting. (opens in a new tab)
- 11 Feb · Board meeting
  Board meeting held on February 11, 2021.We refer to our letter dated 04th February, 2021 and inform that the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2020 were taken on record and approved by the Board of Directors of the Company at its meeting held today i.e. Thursday, 11th February, 2021.We refer to the Regulations 30 and 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 and accordingly enclosed herewith:a. The Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2020.b. Limited Review Report on the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2020.The Board Meeting was commenced at 11.00 a.m. and concluded at 02.00 p.m. (opens in a new tab)
- 4 Feb · Board meeting
  To consider and approve the financial results for the period ended December 31, 2020Pursuant to Regulation 29(1)(a) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, we inform you that a Meeting of the Board of Directors of the Company will be held on Thursday, 11th February, 2021, inter alia, to consider, approve and take on record the Standalone & Consolidated Unaudited Financial Results for the quarter and nine months ended 31st December, 2020. (opens in a new tab)
Nov 2020
- 27 Nov · Board meeting
  Board meeting held on November 27, 2020.Board of Directors of the Company in the Board Meeting has considered and approved the proposal for buyback of up to 3,17,391 (Three Lakhs Seventeen Thousand Three Hundred Ninety One) fully paid up equity shares of the Company having a face value of INR 10/- (Indian Rupees Ten Only) ( Equity Shares and such buyback Buyback ) from all shareholders/ beneficial owners of the Equity Shares of the Company, including promoters and members of the promoter group, through the tender offer route, using mechanism for acquisition of shares through stock exchange as prescribed under Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, as amended (the Buyback Regulations ) and such other circulars or notifications issued by the Securities and Exchange Board of India and the Companies Act, 2013 and rules made thereunder, as amended from time to time, at a price of INR 2,300/- (Indian Rupees Two Thousand Three Hundred Only) per Equity Share ( Buyback Offer Price ), payable in cash, for an aggregate amount not exceeding INR 72,99,99,300/- (Indian Rupees Seventy Two Crores Ninety Nine Lakhs Ninety Nine Thousand Three Hundred only), excluding expenses to be incurred for the Buyback viz. brokerage, costs, fees, turnover charges, taxes such as buyback tax, securities transaction tax and goods and services tax (if any), stamp duty, advisors fees, printing and dispatch expenses and other incidental and related expenses and charges ( Buyback Offer Size ). The resultant Equity Shares to be bought back at the Buyback Offer Price are 3,17,391 Equity Shares, representing 1.52% and 1.45% of the total Equity Shares in the total paid-up equity share capital of the Company as on the date of the Board Meeting and of the total Equity Shares in the total paid-up equity share capital of the Company as on March 31, 2020, respectively (opens in a new tab)

Garware Technical Fibres board meetings

Oct 2026

Jul 2026

May 2026

Feb 2026

Oct 2025

Aug 2025

May 2025

Feb 2025

Jan 2025

Nov 2024

Aug 2024

May 2024

Jan 2024

Nov 2023

Oct 2023

Aug 2023

May 2023

Feb 2023

Oct 2022

Aug 2022

Jul 2022

May 2022

Apr 2022

Feb 2022

Nov 2021

Aug 2021

May 2021

Feb 2021

Nov 2020